Psychotherapy boosts psoriasis clearance. (Stress Reduction Sought).A psoriasis treatment program that included cognitive-behavioral therapy Cognitive-Behavioral Therapy Definition
Cognitive-behavioral therapy is an action-oriented form of psychosocial therapy that assumes that maladaptive, or faulty, thinking patterns cause maladaptive behavior and "negative" emotions. as well as local and systemic treatments controlled the disorder significantly better than dermatologic treatments alone, reported Dr. D.G. Fortune of the University of Manchester The University of Manchester is a university located in Manchester, England. With over 40,000 students studying 500 academic programmes, more than 10,000 staff and an annual income of nearly £600 million it is the largest single-site University in the United Kingdom and receives (England) and associates.
The study shows that effective management of psoriasis should take a holistic approach recognizing the disease's genetic, environmental, social, psychological, and physical aspects, the investigators said (Br. J. Dermatol. 146:458-65, 2002).
In the randomized trial, 93 patients were given the option of receiving 6 weeks of standard care consisting of topical and systemic medications, including phototherapy Phototherapy Definition
Phototherapy, or light therapy, is the administration of doses of bright light in order to normalize the body's internal clock and/or relieve depression. and photochemotherapy, or 6 weeks of participation in the Psoriasis Symptom Management Program (PSMP PSMP Program on Short- and Medium-Range Weather Prediction Research
PSMP Process Safety Management Principles
PSMP Product Support Management Planning
PSMP Product Support Materials Plan ), which included standard care plus six sessions of cognitive-behavioral therapy designed to teach relaxation and stress-reduction techniques and to challenge patients' negative views of the disorder.
A total of 53 patients opted for the standard care regimen; 40 agreed to participate in PSMP. At the study's outset, there were no significant differences between the two groups in demographics, clinical history, or clinical severity of psoriasis.
Evaluations of clinical severity of the psoriasis and patient-reported disability, anxiety, depression, and stress related to psoriasis were measured at outset, at 6 weeks, and at 6 months of follow-up.
Of the PSMP patients, 64% achieved a 75% or greater clearance of their psoriasis at 6 months; 23% of the standard therapy patients achieved a 75% or greater clearance of their psoriasis at 6 months.